AR085297A1 - METODOS PARA MEJORAR EL DESARROLLO DEL CEREBRO Y LA FUNCION COGNITIVA EN LOS QUE SE EMPLEA b-HIDROXI-b-METILBUTIRATO - Google Patents
METODOS PARA MEJORAR EL DESARROLLO DEL CEREBRO Y LA FUNCION COGNITIVA EN LOS QUE SE EMPLEA b-HIDROXI-b-METILBUTIRATOInfo
- Publication number
- AR085297A1 AR085297A1 ARP120100566A AR085297A1 AR 085297 A1 AR085297 A1 AR 085297A1 AR P120100566 A ARP120100566 A AR P120100566A AR 085297 A1 AR085297 A1 AR 085297A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- improve
- methylbutirate
- brain
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pediatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161443762P | 2011-02-17 | 2011-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR085297A1 true AR085297A1 (es) | 2013-09-18 |
Family
ID=45757211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120100566 AR085297A1 (es) | 2011-02-17 | 2012-02-17 | METODOS PARA MEJORAR EL DESARROLLO DEL CEREBRO Y LA FUNCION COGNITIVA EN LOS QUE SE EMPLEA b-HIDROXI-b-METILBUTIRATO |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9326956B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2675298A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6034309B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103347406B (cg-RX-API-DMAC7.html) |
| AR (1) | AR085297A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112013020643A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2825734C (cg-RX-API-DMAC7.html) |
| MX (1) | MX348708B (cg-RX-API-DMAC7.html) |
| PH (1) | PH12013501671A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG192813A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI565420B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012112419A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG182812A1 (en) | 2010-01-29 | 2012-09-27 | Abbott Lab | Nutritional emulsions comprising calcium hmb |
| WO2011094548A1 (en) | 2010-01-29 | 2011-08-04 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising hmb |
| US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
| TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
| US9326956B2 (en) | 2011-02-17 | 2016-05-03 | Abbott Laboratories | Methods for improving brain development and cognitive function using beta-hydroxy-beta methylbutyrate |
| ES2421187B1 (es) * | 2012-02-23 | 2014-11-26 | Abbott Laboratories | Metodo para mejorar el desarrollo cerebral y la funcion cognitiva usando beta-hidroxi-beta-metilbutirato |
| EP2745708A1 (en) * | 2012-12-24 | 2014-06-25 | Abbott Laboratories, Inc. | Antidepressant effect of ß-hydroxy-ß-methylbutyrate |
| US20150351438A1 (en) * | 2013-01-29 | 2015-12-10 | Otc Nutrition Llc | Micronutrient Fortification Delivery |
| WO2014127112A1 (en) * | 2013-02-13 | 2014-08-21 | Baylor College Of Medicine | Memory enhancer and actin dynamics |
| US20160029683A1 (en) * | 2013-03-15 | 2016-02-04 | Abbott Laboratories | Low calorie infant formula containing beta-hydroxy-beta-methylbutyric acid |
| WO2015148982A1 (en) | 2014-03-27 | 2015-10-01 | Winterfield Roland W | Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy |
| WO2017048708A1 (en) * | 2015-09-16 | 2017-03-23 | Abbott Laboratories | Reduced fat, shelf stable liquid nutritional composition |
| BR112018009406A8 (pt) * | 2015-11-10 | 2019-02-26 | Metabolic Tech Inc | ?composição de aditivo de ração, produto de ração, método para prevenir, eliminar e/ou reduzir crescimento microbiano, e, revestimento para um produto de ração animal? |
| JP7011300B2 (ja) * | 2017-12-19 | 2022-02-10 | 株式会社島田製薬 | HMBCa含有顆粒の製造方法、及びサプリメント |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291525B1 (en) * | 1999-09-08 | 2001-09-18 | Iowa State University Research Foundation, Inc. | Method for improving a human's perception of his emotional state |
| US7445807B2 (en) | 2002-10-15 | 2008-11-04 | Western Holdings, Llc | Agglomerated granular protein-rich nutritional supplement |
| US20050027005A1 (en) | 2003-08-02 | 2005-02-03 | Matthias Boldt | Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner |
| US20050215640A1 (en) | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| PL371081A1 (pl) | 2004-11-08 | 2006-05-15 | Sgp & Sons Ab | Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt |
| US20060167075A1 (en) | 2005-01-25 | 2006-07-27 | Pearson James P | Modulators of FAAH |
| US20080317886A1 (en) * | 2005-11-03 | 2008-12-25 | Sparkman Dennis R | Compositions for Preventing and Reducing Delayed Onset Muscle Soreness |
| ES2548432T3 (es) | 2005-12-19 | 2015-10-16 | Abbott Laboratories | Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2 |
| WO2009116546A1 (ja) | 2008-03-18 | 2009-09-24 | 国立大学法人 岡山大学 | 興奮性化学伝達調節剤およびそのスクリーニング法 |
| DK2381784T3 (en) | 2008-12-09 | 2018-10-22 | Metabolic Tech Inc | Nutritional intervention to improve muscle function and strength |
| JP2009155336A (ja) * | 2009-03-31 | 2009-07-16 | Tsujido Chemical Corp | 治療剤 |
| TW201117736A (en) | 2009-11-17 | 2011-06-01 | Hui-Chiang Lu | Compositions for sport supplement |
| CN101785566A (zh) | 2010-01-22 | 2010-07-28 | 北京康比特体育科技股份有限公司 | 一种含有hmb的运动饮料 |
| CN103338658A (zh) | 2010-12-22 | 2013-10-02 | 雅培制药有限公司 | 含有β-羟基-β甲基丁酸钙和共轭亚油酸的营养型产品 |
| EP2658535A1 (en) | 2010-12-27 | 2013-11-06 | Abbott Laboratories | Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate |
| US9326956B2 (en) | 2011-02-17 | 2016-05-03 | Abbott Laboratories | Methods for improving brain development and cognitive function using beta-hydroxy-beta methylbutyrate |
| SG11201405905WA (en) | 2012-03-19 | 2014-11-27 | Abbott Lab | Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance |
| MX2015003498A (es) | 2012-09-17 | 2015-06-04 | Abbott Lab | Composiciones que contienen acido beta-hidroxi-beta-metilbutirico y usos de las mismas. |
-
2012
- 2012-02-13 US US13/984,906 patent/US9326956B2/en not_active Expired - Fee Related
- 2012-02-13 CA CA2825734A patent/CA2825734C/en not_active Expired - Fee Related
- 2012-02-13 MX MX2013009528A patent/MX348708B/es active IP Right Grant
- 2012-02-13 CN CN201280009207.4A patent/CN103347406B/zh not_active Expired - Fee Related
- 2012-02-13 SG SG2013062377A patent/SG192813A1/en unknown
- 2012-02-13 EP EP12705748.7A patent/EP2675298A1/en not_active Withdrawn
- 2012-02-13 JP JP2013554520A patent/JP6034309B2/ja not_active Expired - Fee Related
- 2012-02-13 WO PCT/US2012/024817 patent/WO2012112419A1/en not_active Ceased
- 2012-02-13 PH PH1/2013/501671A patent/PH12013501671A1/en unknown
- 2012-02-13 BR BR112013020643A patent/BR112013020643A2/pt not_active IP Right Cessation
- 2012-02-17 TW TW101105347A patent/TWI565420B/zh not_active IP Right Cessation
- 2012-02-17 AR ARP120100566 patent/AR085297A1/es not_active Application Discontinuation
-
2016
- 2016-10-26 JP JP2016209276A patent/JP6340394B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103347406B (zh) | 2015-08-05 |
| PH12013501671A1 (en) | 2021-06-02 |
| TWI565420B (zh) | 2017-01-11 |
| CA2825734A1 (en) | 2012-08-23 |
| TW201309212A (zh) | 2013-03-01 |
| US20140249223A1 (en) | 2014-09-04 |
| WO2012112419A8 (en) | 2014-03-06 |
| US9326956B2 (en) | 2016-05-03 |
| JP2017061483A (ja) | 2017-03-30 |
| CN103347406A (zh) | 2013-10-09 |
| SG192813A1 (en) | 2013-09-30 |
| BR112013020643A2 (pt) | 2016-08-02 |
| JP6340394B2 (ja) | 2018-06-06 |
| WO2012112419A1 (en) | 2012-08-23 |
| JP6034309B2 (ja) | 2016-11-30 |
| CA2825734C (en) | 2016-05-17 |
| JP2014506890A (ja) | 2014-03-20 |
| MX2013009528A (es) | 2013-10-01 |
| MX348708B (es) | 2017-06-26 |
| EP2675298A1 (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR132544A2 (es) | ANTICUERPOS PEPTÍDICOS b AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
| CU20160151A7 (es) | 2-AMIN0-6-METI L-4,4a, 5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS | |
| DOP2014000174A (es) | Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas | |
| ECSP12011692A (es) | Derivados de oxazina y su uso en el tratamiento de los trastornos neurológicos | |
| PH12013501671A1 (en) | Methods for improving brain development and cognitive function using beta-hydroxy-beta-methylbutyrate | |
| NZ720949A (en) | Methods and compositions for treating aging-associated conditions | |
| MX2020001360A (es) | Macrociclos de diarilo como moduladores de la proteina quinasa. | |
| MX2021000954A (es) | Terapia de aumento mitocondrial con celulas madre enriquecidas con mitocondrias funcionales. | |
| UY33883A (es) | Novedosos derivados heterocíclicos | |
| SV2016005311A (es) | Compuestos y composiciones como agonistas del receptor tipo toll 7 | |
| MX353482B (es) | Metodos para el tratamiento del cancer y enfermedades inflamatorias utilizando cereblon como predictor. | |
| MX2014010625A (es) | Inhibidores de la beta-secretasa. | |
| CR20160542A (es) | 1 H-PIRROLO[2,3-c]PIRIDIN-7(6H)-ONAS YPIRAZOLO[3,4-c]PlRIDIN-7(6H)-ONAS COMO INHIBIDORES DE PROTEINAS BET | |
| CO2017000346A2 (es) | Anticuerpos de unión a protofibrillas aβ | |
| GT201400222A (es) | Agentes para tratar trastornos que implican la modulación de receptores de rianodina | |
| CO6731117A2 (es) | Metodos para diagnosticar y tratar desórdenes relacionados con la longitud axial del ojo | |
| PE20150631A1 (es) | Formas cristalinas de un modulador del receptor androgenico | |
| MX2018011453A (es) | Moduladores alostericos de receptores de acetilcolina nicotinicos. | |
| UY33206A (es) | Métodos de tratamiento de enfermedades autoinmunes con antagonistas de dll4 | |
| MX383535B (es) | Terapias para el tratamiento de enfermedades asociadas con la toxicidad del aldehído. | |
| MX385855B (es) | Uso de la 2-fucosil-lactosa para aumentar la funcionalidad cerebral. | |
| UY33277A (es) | Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso | |
| MA45329A (fr) | Production de cellules bêta matures pleinement fonctionnelles à partir de progénitrices pancréatiques humaines | |
| ECSP13012824A (es) | Derivados de (1,2,4)triazolo[4,3-a)quinoxalina como inhibidores de fosfodiesterasas | |
| UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |